Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 9, 2026
October 9, 2026
d8b2afc2-4d89-4b73-8d18-023369abff5b
Related Documents
Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers
Guidance DocumentOctober 9, 2026Center for Drug Evaluation and Research
Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Guidance DocumentMarch 9, 2026Center for Drug Evaluation and Research
Q8, Q9, and Q10 Questions and Answers (R5)
Guidance DocumentMay 29, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.